Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bartels

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Oncotarget|July 25, 2016
Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancerCallie R Merry, Sarah McMahon, Megan E Forrest, et al.
Genome Medicine|May 30, 2012
H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sitesDheepa Balasubramanian, Batool Akhtar-Zaidi, Lingyun Song, et al.
Plos Genetics|July 27, 2010
CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expressionMichael P Schnetz, Lusy Handoko, Batool Akhtar-Zaidi, et al.
Cell Stem Cell|October 22, 2020
Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell FunctionKevin C Allan, Lucille R Hu, Marissa A Scavuzzo, et al.
Human Mutation|January 30, 2009
A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeatsBoi-Dinh Chung, Hülya Kayserili, Minrong Ai, et al.
Elife|February 14, 2019
Mismatch repair-signature mutations activate gene enhancers across human colorectal cancer epigenomesStevephen Hung, Alina Saiakhova, Zachary J Faber, et al.
Science (New York, N.Y.)|April 14, 2012
Epigenomic enhancer profiling defines a signature of colon cancerBatool Akhtar-Zaidi, Richard Cowper-Sal-lari, Olivia Corradin, et al.
Cancer Research|September 20, 2022
Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell SubsetsDefne Bayik, Cynthia F Bartels, Katreya Lovrenert, et al.
Cancer Research|May 15, 2023
Correction: Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell SubsetsDefne Bayik, Cynthia F Bartels, Katreya Lovrenert, et al.
Molecular Psychiatry|March 18, 2022
Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdoseOlivia Corradin, Richard Sallari, An T Hoang, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Oncotarget|July 25, 2016
Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancerCallie R Merry, Sarah McMahon, Megan E Forrest, et al.
Genome Medicine|May 30, 2012
H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sitesDheepa Balasubramanian, Batool Akhtar-Zaidi, Lingyun Song, et al.
Plos Genetics|July 27, 2010
CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expressionMichael P Schnetz, Lusy Handoko, Batool Akhtar-Zaidi, et al.
Cell Stem Cell|October 22, 2020
Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell FunctionKevin C Allan, Lucille R Hu, Marissa A Scavuzzo, et al.
Human Mutation|January 30, 2009
A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeatsBoi-Dinh Chung, Hülya Kayserili, Minrong Ai, et al.
Elife|February 14, 2019
Mismatch repair-signature mutations activate gene enhancers across human colorectal cancer epigenomesStevephen Hung, Alina Saiakhova, Zachary J Faber, et al.
Science (New York, N.Y.)|April 14, 2012
Epigenomic enhancer profiling defines a signature of colon cancerBatool Akhtar-Zaidi, Richard Cowper-Sal-lari, Olivia Corradin, et al.
Cancer Research|September 20, 2022
Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell SubsetsDefne Bayik, Cynthia F Bartels, Katreya Lovrenert, et al.
Cancer Research|May 15, 2023
Correction: Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell SubsetsDefne Bayik, Cynthia F Bartels, Katreya Lovrenert, et al.
Molecular Psychiatry|March 18, 2022
Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdoseOlivia Corradin, Richard Sallari, An T Hoang, et al.
Pageof 15